HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses

Journal:

Journal of Hepatology

Published:

2025-10-17

DOI:

10.1016/j.jhep.2025.09.033

Affiliations:

7

Authors:

20

Go to article

Institutions	Authors	Share
State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, China	9.000000	0.45
Nankai University (NKU), China	6.000000	0.30
The First Hospital of Jilin University, China	2.333333	0.12
Beijing Vitalstar Biotechnology Co., Ltd., China	2.000000	0.10
Jilin University (JLU), China	0.333333	0.02
China-Singapore Belt and Road Joint Laboratory on Liver Disease Research, China	0.333333	0.02

Interested in Medical Microbiology?